 insulin resist earli metabol defect turner syndrom insulin resist contribut risk diabet patient turner syndrom insulin sensit euglycem insulin clamp techniqu whole bodi glucos lipid oxid indirect calorimetri group nondiabet patient turner syndrom age-match normal control group young patient mean age yr hormon therapi group patient mean age yr estrogen therapi group glucos euglycem clamp hepat sensit euglycem clamp insulin-stimul glucos metabol group patient group control group control impair insulin-stimul glucos metabol patient turner syndrom reduc nonoxid glucos dispos glucos oxid similar extent turner patient normal control insulin-induc suppress hepat glucos product group plasma ffa chain amino acid level turner patient indistinguish normal control data patient turner syndrom insulin resist earli metabol nonoxid pathway intracellular glucos metabol